HaniSalehi-HadMD
Ophthalmology • Huntington Beach, CARetinal Disease
Retina Associates of Southern California
Dr. Salehi-Had is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7812 Edinger Ave
Suite 202
Huntington Beach, CA 92647Phone+1 714-901-2006Fax+1 714-901-2004
Summary
- Dr. Hani Salehi-Had is an ophthalmologist in Huntington Beach, CA and is affiliated with multiple hospitals in the area, including Hoag Memorial Hospital Presbyterian, MemorialCare, Orange Coast Memorial Medical Center, MemorialCare, Long Beach Memorial Medical Center, Los Alamitos Medical Center, and Torrance Memorial Medical Center. He received his medical degree from University of California Davis School of Medicine and has been in practice 12 years. He specializes in retinal disease and is experienced in diabetic retinopathy, retinal detachment, optical coherence tomography, ocular trauma, and macular degeneration.
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Surgical Retina and Vitreous, 2009 - 2011
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2006 - 2009
St Mary's Hospital and Medical CenterInternship, Internal Medicine, 2005 - 2006
University of California, Davis, School of MedicineClass of 2005
Certifications & Licensure
CA State Medical License 2009 - 2026- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Phase II Combination Steroid and Anti-VEGF for Persistent DME Start of enrollment: 2014 Feb 01
- Efficacy and Safety of RTH258 Versus Aflibercept - Study 1 Start of enrollment: 2014 Dec 08
- Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration Start of enrollment: 2015 Jun 25
Publications & Presentations
PubMed
- 5 citationsLong-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.Mark S Humayun, Dennis O Clegg, Margot S Dayan, Amir H Kashani, Firas M Rahhal
Ophthalmology. 2024-06-01 - 5 citationsIntravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.David M Brown, David S Boyer, Diana V Do, Charles C Wykoff, Taiji Sakamoto
Lancet. 2024-03-23 - 16 citationsFour-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.Raj K Maturi, Adam R Glassman, Kristin Josic, Carl W Baker, Adam T Gerstenblith
JAMA. 2023-02-07
Professional Memberships
- Member
- Member
External Links
- Retina Associates of Southern California https://retinasocal.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
